Literature DB >> 24249679

Interaction of delta-like 1 homolog (Drosophila) with prohibitins and its impact on tumor cell clonogenicity.

Asma Begum1, Qun Lin, Chenye Yu, Yuri Kim, Zhong Yun.   

Abstract

UNLABELLED: Cancer stem cell characteristics, especially their self-renewal and clonogenic potentials, play an essential role in malignant progression and response to anticancer therapies. Currently, it remains largely unknown what pathways are involved in the regulation of cancer cell stemness and differentiation. Previously, we found that delta-like 1 homolog (Drosophila) or DLK1, a developmentally regulated gene, plays a critical role in the regulation of differentiation, self-renewal, and tumorigenic growth of neuroblastoma cells. Here, we show that DLK1 specifically interacts with the prohibitin 1 (PHB1) and PHB2, two closely related genes with pleiotropic functions, including regulation of mitochondrial function and gene transcription. DLK1 interacts with the PHB1-PHB2 complex via its cytoplasmic domain and regulates mitochondrial functions, including mitochondrial membrane potential and production of reactive oxygen species. We have further found that PHB1 and especially PHB2 regulate cancer cell self-renewal as well as their clonogenic potential. Hence, the DLK1-PHB interaction constitutes a new signaling pathway that maintains clonogenicity and self-renewal potential of cancer cells. IMPLICATIONS: This study provides a new mechanistic insight into the regulation of the stem cell characteristics of cancer cells. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24249679      PMCID: PMC3946965          DOI: 10.1158/1541-7786.MCR-13-0360

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  40 in total

Review 1.  The role of the epidermal growth factor-like protein dlk in cell differentiation.

Authors:  J Laborda
Journal:  Histol Histopathol       Date:  2000-01       Impact factor: 2.303

2.  Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression.

Authors:  Sheng Wang; Gina Fusaro; Jaya Padmanabhan; Srikumar P Chellappan
Journal:  Oncogene       Date:  2002-12-05       Impact factor: 9.867

Review 3.  New control of mitochondrial membrane potential and ROS formation--a hypothesis.

Authors:  I Lee; E Bender; S Arnold; B Kadenbach
Journal:  Biol Chem       Date:  2001-12       Impact factor: 3.915

4.  High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type.

Authors:  Vera A E Van Limpt; Alvin J Chan; Peter G Van Sluis; Huib N Caron; Carel J M Van Noesel; Rogier Versteeg
Journal:  Int J Cancer       Date:  2003-05-20       Impact factor: 7.396

5.  Only the large soluble form of preadipocyte factor-1 (Pref-1), but not the small soluble and membrane forms, inhibits adipocyte differentiation: role of alternative splicing.

Authors:  Baisong Mei; Ling Zhao; Li Chen; Hei Sook Sul
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

Review 6.  Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics.

Authors:  Qun Lin; Zhong Yun
Journal:  Cancer Biol Ther       Date:  2010-06-11       Impact factor: 4.742

Review 7.  Pref-1 and ADSF/resistin: two secreted factors inhibiting adipose tissue development.

Authors:  J A Villena; K H Kim; H S Sul
Journal:  Horm Metab Res       Date:  2002 Nov-Dec       Impact factor: 2.936

8.  dlk, a putative mammalian homeotic gene differentially expressed in small cell lung carcinoma and neuroendocrine tumor cell line.

Authors:  J Laborda; E A Sausville; T Hoffman; V Notario
Journal:  J Biol Chem       Date:  1993-02-25       Impact factor: 5.157

9.  Akt binds prohibitin 2 and relieves its repression of MyoD and muscle differentiation.

Authors:  Luguo Sun; Lanying Liu; Xiang-Jiao Yang; Zhenguo Wu
Journal:  J Cell Sci       Date:  2004-06-01       Impact factor: 5.285

10.  Prohibitin requires Brg-1 and Brm for the repression of E2F and cell growth.

Authors:  Sheng Wang; Baohua Zhang; Douglas V Faller
Journal:  EMBO J       Date:  2002-06-17       Impact factor: 11.598

View more
  4 in total

1.  Analysis of the Paternally-Imprinted DLK1-MEG3 and IGF2-H19 Tandem Gene Loci in NT2 Embryonal Carcinoma Cells Identifies DLK1 as a Potential Therapeutic Target.

Authors:  Zachariah Payne Sellers; Gabriela Schneider; Magdalena Maj; Mariusz Z Ratajczak
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

Review 2.  DLK1-DIO3 imprinted cluster in induced pluripotency: landscape in the mist.

Authors:  Leonidas Benetatos; George Vartholomatos; Eleftheria Hatzimichael
Journal:  Cell Mol Life Sci       Date:  2014-08-07       Impact factor: 9.261

3.  Tissue-based quantitative proteomics to screen and identify the potential biomarkers for early recurrence/metastasis of esophageal squamous cell carcinoma.

Authors:  Xu-Wei Cai; Wei-Wei Yu; Wen Yu; Qin Zhang; Wen Feng; Mi-Na Liu; Meng-Hong Sun; Jia-Qing Xiang; Ya-Wei Zhang; Xiao-Long Fu
Journal:  Cancer Med       Date:  2018-04-23       Impact factor: 4.452

Review 4.  Cancer Stem Cells in Neuroblastoma: Expanding the Therapeutic Frontier.

Authors:  Hisham F Bahmad; Farah Chamaa; Sahar Assi; Reda M Chalhoub; Tamara Abou-Antoun; Wassim Abou-Kheir
Journal:  Front Mol Neurosci       Date:  2019-05-27       Impact factor: 5.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.